{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:26:53Z","timestamp":1793190413925,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["310295"],"award-info":[{"award-number":["310295"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.euroneuro.2022.05.012","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T12:37:53Z","timestamp":1656160673000},"page":"36-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-855X","authenticated-orcid":false,"given":"M.","family":"Holm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3795-3126","authenticated-orcid":false,"given":"A.","family":"Tanskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7244-145X","authenticated-orcid":false,"given":"M.","family":"L\u00e4hteenvuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0400-6798","authenticated-orcid":false,"given":"J.","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Taipale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2022.05.012_bib0001","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jad.2020.09.016","article-title":"Suicide mortality and use of psychotropic drugs in patients hospitalized due to bipolar disorder: a Finnish nationwide cohort study","volume":"277","author":"Antol\u00edn-Concha","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0002","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jad.2020.03.030","article-title":"Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis","volume":"269","author":"Bahji","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0003","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(09)61828-6","article-title":"Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial","volume":"375","author":"Geddes","year":"2010","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1017\/neu.2015.52","article-title":"Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study","volume":"28","author":"Bj\u00f8rklund","year":"2016","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0005","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0006","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4088\/JCP.14r09245","article-title":"Recovery and recurrence following a first episode of mania: a systematic review and meta-analysis of prospectively characterized cohorts","volume":"76","author":"Gignac","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0007","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13696998.2017.1379412","article-title":"Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder","volume":"21","author":"Greene","year":"2018","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0008","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/wps.20298","article-title":"Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records","volume":"15","author":"Hayes","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0009","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/2045125318804364","article-title":"Medication nonadherence in bipolar disorder: a narrative review","volume":"8","author":"Jawad","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1192\/bjp.bp.116.187989","article-title":"Pharmacological treatment and risk of psychiatric hospital admission in bipolar disorder","volume":"210","author":"Joas","year":"2017","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0011","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40263-019-00629-z","article-title":"Long-acting injectable second-generation\/atypical antipsychotics for the management of bipolar disorder: a systematic review","volume":"33","author":"Keramatian","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0012","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1399-5618.2007.00405.x","article-title":"Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study","volume":"9","author":"Kessing","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0013","series-title":"Tautiluokitus 1987: Osa 1: Systemaattinen Osa","year":"1987"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0014","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jamapsychiatry.2017.4711","article-title":"Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a finnish nationwide cohort of patients with bipolar disorder","volume":"75","author":"L\u00e4hteenvuo","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12888-018-1622-1","article-title":"Reasons for lithium discontinuation in men and women with bipolar disorder: a retrospective cohort study","volume":"18","author":"\u00d6hlund","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0017","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1017\/S0033291721001446","article-title":"Mapping modifiable determinants of medication adherence in bipolar disorder (BD) to the theoretical domains framework (TDF): a systematic review","volume":"51","author":"Prajapati","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0018","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/bdi.12707","article-title":"Second-generation antipsychotic long-acting injections in bipolar disorder: systematic review and meta-analysis","volume":"20","author":"Prajapati","year":"2018","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0019","series-title":"R: A language and Environment For Statistical Computing","year":"2022"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0020","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320905752","article-title":"Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data","volume":"10","author":"Stahl","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0021","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/CLEP.S116160","article-title":"Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons","volume":"8","author":"Taipale","year":"2016","journal-title":"Clin. Epidemiol. Volume"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184070","article-title":"Drug exposure in register-based research\u2014an expert-opinion based evaluation of methods","volume":"12","author":"Tanskanen","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12911-015-0140-z","article-title":"From prescription drug purchases to drug use periods \u2013 a second generation method (PRE2DUP)","volume":"15","author":"Tanskanen","year":"2015","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0024","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40261-017-0592-2","article-title":"A review of asenapine in the treatment of bipolar disorder","volume":"38","author":"Vieta","year":"2018","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0025","series-title":"ATC\/DDD Index 2021. Oslo, Norway","year":"2020"},{"key":"10.1016\/j.euroneuro.2022.05.012_bib0026","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0033291714001305","article-title":"A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania","volume":"45","author":"Yildiz","year":"2015","journal-title":"Psychol. Med."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22002127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22002127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:03:26Z","timestamp":1760378606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X22002127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":26,"alternative-id":["S0924977X22002127"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.05.012","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}